PAI
SPPI

Palo Alto Investors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Palo Alto Investors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-402,285
Closed -$3.15M – 43
2014
Q1 		$3.15M Hold
402,285
– – 0.26% 28
2013
Q4 		$3.56M Buy
402,285
+6,300
+2% +$56.3K 0.33% 27
2013
Q3 		$3.32M Hold
395,985
– – 0.35% 26
2013
Q2 		$2.95M Buy
+395,985
New +$3.04M 0.35% 26

Other funds holding SPPI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Palo Alto Investors's SPPI Position: Q2 2014 in Review

Palo Alto Investors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2014, closing a stake of 402,285 shares — an estimated $3.15M sold.

Palo Alto Investors first reported a position in SPPI in Q2 2013 and held it in 4 quarters. The position peaked at $3.56M in Q4 2013. 126 funds tracked by Wall St. Rank hold SPPI as of Q2 2014.

  • Palo Alto Investors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Palo Alto Investors sold 402,285 Spectrum Pharmaceuticals Inc shares in Q2 2014, an estimated $3.15M.
  • Palo Alto Investors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Palo Alto Investors's Spectrum Pharmaceuticals Inc position peaked at $3.56M in Q4 2013.
  • 126 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2014.

Based on Palo Alto Investors's 13F filing for Q2 2014, filed 14 Aug 2014.